Interrelationships between sarcopenia, bone turnover markers and low bone mineral density in patients on hemodialysis

References

• Erratum: kidney Disease: improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). kidney int suppl. 2017;7:1–59. Kidney Int Suppl 2017;7(3):1.
   Web of Science ®Google Scholar
• Goldenstein PT, Jamal SA, Moysés RM. Fractures in chronic kidney disease: pursuing the best screening and management. Curr Opin Nephrol Hypertens. 2015;24(4):317–10.
   PubMed Web of Science ®Google Scholar
• Maravic M, Ostertag A, Torres PU, et al. Incidence and risk factors for hip fractures in dialysis patients. Osteoporos Int. 2014;25(1):159–165.
   PubMed Web of Science ®Google Scholar
• Tentori F, McCullough K, Kilpatrick RD, et al. High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int. 2013;85(1):166–173.
   Web of Science ®Google Scholar
• Yu TM, Lin CL, Shu KH, et al. Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study. Osteoporos Int. 2015;26(2):785–793.
   PubMed Web of Science ®Google Scholar
• Kim CS, Bae EH, Ma SK, et al. Chronic kidney disease-mineral bone disorder in Korean patients: a report from the Korean cohort study for outcomes in patients with chronic kidney disease (KNOW-CKD). J Korean Med Sci. 2017;32(2):240–248.
   PubMed Web of Science ®Google Scholar
• Isoyama N, Qureshi AR, Avesani CM, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol. 2014;9(10):1720–1728.
   PubMed Web of Science ®Google Scholar
• Iseri K, Qureshi AR, Dai L, et al. Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: a cohort study. Bone. 2020;130:115075.
   PubMed Web of Science ®Google Scholar
• Binkley N, Buehring B. Beyond FRAX: it’s time to consider "sarco-osteopenia. J Clin Densitom. 2009;12(4):413–416.
   PubMed Web of Science ®Google Scholar
• Kirk B, Zanker J, Duque G. Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers. J Cachexia Sarcopenia Muscle. 2020;11(3):609–618.
   PubMed Web of Science ®Google Scholar
• Tangvoraphonkchai K, Davenport A. Pre-dialysis and post-dialysis hydration status and N-terminal pro-brain natriuretic peptide and survival in haemodialysis patients. Int J Artif Organs. 2016;39(6):282–287.
   PubMed Web of Science ®Google Scholar
• Davies SJ, Davenport A. The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int. 2014;86(3):489–496.
   PubMed Web of Science ®Google Scholar
• Sabatino A, Broers N, van der Sande FM, et al. Estimation of muscle mass in the integrated assessment of patients on hemodialysis. Front Nutr. 2021;8:697523.
   PubMed Web of Science ®Google Scholar
• Kim CR, Shin JH, Hwang JH, et al. Monitoring volume status using bioelectrical impedance analysis in chronic hemodialysis patients. Asaio J. 2018;64(2):245–252.
   PubMed Web of Science ®Google Scholar
• Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2.
   PubMed Web of Science ®Google Scholar
• Dimai HP. Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases. Bone. 2017;104:39–43.
   PubMed Web of Science ®Google Scholar
• Hirschfeld HP, Kinsella R, Duque G. Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int. 2017;28(10):2781–2790.
   PubMed Web of Science ®Google Scholar
• Montenegro J, Klein M, Bregman R, et al. Osteosarcopenia in patients with non-dialysis dependent chronic kidney disease. Clin Nutr. 2022;41(6):1218–1227.
   PubMed Web of Science ®Google Scholar
• Moldovan D, Moldovan I, Rusu C, et al. Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them. Int Urol Nephrol. 2011;43(4):1179–1186.
   PubMed Web of Science ®Google Scholar
• Wang YJ, Wang Y, Zhan JK, et al. Sarco-osteoporosis: prevalence and association with frailty in Chinese community-dwelling older adults. Int J Endocrinol. 2015;2015:482940.
   PubMed Web of Science ®Google Scholar
• Huo YR, Suriyaarachchi P, Gomez F, et al. Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Dir Assoc. 2015;16(4):290–295.
   PubMed Web of Science ®Google Scholar
• Yoo JI, Kim H, Ha YC, et al. Osteosarcopenia in patients with hip fracture is related with high mortality. J Korean Med Sci. 2018;33(4):e27.
   PubMed Web of Science ®Google Scholar
• Ito K, Ookawara S, Hibino Y, et al. Skeletal muscle mass index is positively associated with bone mineral density in hemodialysis patients. Front Med. 2020;7:187.
   Web of Science ®Google Scholar
• Chen SC, Chung WS, Wu PY, et al. Associations among geriatric nutrition risk index, bone mineral density, body composition and handgrip strength in patients receiving hemodialysis. Nutrition. 2019;65:6–12.
   PubMed Web of Science ®Google Scholar
• Tominaga H, Oku M, Arishima Y, et al. Association between bone mineral density, muscle volume, walking ability, and geriatric nutritional risk index in hemodialysis patients. Asia Pac J Clin Nutr. 2018;27(5):1062–1066.
   PubMed Web of Science ®Google Scholar
• Hassan EB, Duque G. Osteosarcopenia: a new geriatric syndrome. Aust Fam Physician. 2017;46(11):849–853.
   PubMedGoogle Scholar
• Dolan E, Sale C. Protein and bone health across the lifespan. Proc Nutr Soc. 2019;78(1):45–55.
   PubMed Web of Science ®Google Scholar
• Maurel DB, Jähn K, Lara-Castillo N. Muscle-Bone crosstalk: emerging opportunities for novel therapeutic approaches to treat musculoskeletal pathologies. Biomedicines. 2017;5(4):62.
   PubMed Web of Science ®Google Scholar
• Garcia LA, King KK, Ferrini MG, et al. 1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology. 2011;152(8):2976–2986.
   PubMed Web of Science ®Google Scholar
• Lebrasseur NK, Achenbach SJ, Melton LJ, 3rd, et al. Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men. J Bone Miner Res. 2012;27(10):2159–2169.
   PubMed Web of Science ®Google Scholar
• Rariy CM, Ratcliffe SJ, Weinstein R, et al. Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study. J Clin Endocrinol Metab. 2011;96(4):989–996.
   PubMed Web of Science ®Google Scholar
• Ho-Pham LT, Nguyen UD, Nguyen TV. Association between lean mass, fat mass, and bone mineral density: a meta-analysis. J Clin Endocrinol Metab. 2014;99(1):30–38.
   PubMed Web of Science ®Google Scholar
• Kazama JJ, Wakasugi M. Parathyroid hormone and bone in dialysis patients. Ther Apher Dial. 2018;22(3):229–235.
   PubMed Web of Science ®Google Scholar
• Moldovan D, Rusu C, Potra A, et al. Osteoprotegerin and uremic osteoporosis in chronic hemodialysis patients. Int Urol Nephrol. 2017;49(5):895–901.
   PubMed Web of Science ®Google Scholar
• Henriksen K, Tanko LB, Qvist P, et al. Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases. Osteoporos Int. 2007;18(5):681–685.
   PubMed Web of Science ®Google Scholar
• Iseri K, Watanabe M, Yoshikawa H, et al. Effects of denosumab and alendronate on bone health and vascular function in hemodialysis patients: a randomized, controlled trial. J Bone Miner Res. 2019;34(6):1014–1024.
   PubMed Web of Science ®Google Scholar
• Wintermeyer E, Ihle C, Ehnert S, et al. Crucial role of vitamin D in the musculoskeletal system. Nutrients. 2016;8(6):319.
   PubMed Web of Science ®Google Scholar
• Kawao N, Kaji H. Interactions between muscle tissues and bone metabolism. J Cell Biochem. 2015;116(5):687–695.
   PubMed Web of Science ®Google Scholar
• Covic A, Vervloet M, Massy ZA, et al. Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. Lancet Diabetes Endocrinol. 2018;6(4):319–331.
   PubMed Web of Science ®Google Scholar